In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy (2016)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1007/s00228-015-1985-x
- Subjects: ENDOTÉLIO VASCULAR; HIPERTENSÃO; POLIMORFISMO; VASODILATAÇÃO
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2016
- Source:
- Título do periódico: European Journal of Clinical Pharmacology
- ISSN: 0031-6970
- Volume/Número/Paginação/Ano: v. 72, n. 1, p. 127-128, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
OLIVEIRA-PAULA, G. H. e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy. European Journal of Clinical Pharmacology. Heidelberg: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00228-015-1985-x. Acesso em: 23 abr. 2024. , 2016 -
APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2016). In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy. European Journal of Clinical Pharmacology. Heidelberg: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s00228-015-1985-x -
NLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 1): 127-128.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s00228-015-1985-x -
Vancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 1): 127-128.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s00228-015-1985-x - Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endotélio e genética
- Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects
- Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population
- Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels
Informações sobre o DOI: 10.1007/s00228-015-1985-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas